
Alpha Profiles · Company Profile
Bicara Therapeutics Inc.
Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts.
https://registry.alpha.ac/companies/bicara-therapeutics-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: BCAX
- Verification
- Partially verified
- Last reviewed
- 2026-09-21T04:46:04.996939+00:00
Overview
Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers. This bifunctional therapeutic agent works by simultaneously engaging the epidermal growth factor receptor (EGFR) and binding to human transfo
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-09-21T04:46:04.996939+00:00
